Structural classification of CDR‐H3 revisited: A lesson in antibody modeling

Among the six complementarity‐determining regions (CDRs) in the variable domains of an antibody, the third CDR of the heavy chain (CDR‐H3), which lies in the center of the antigen‐binding site, plays a particularly important role in antigen recognition. CDR‐H3 shows significant variability in its length, sequence, and structure. Although difficult, model building of this segment is the most critical step in antibody modeling. Since our first proposal of the “H3‐rules,” which classify CDR‐H3 structure based on amino acid sequence, the number of experimentally determined antibody structures has increased. Here, we revise these H3‐rules and propose an improved classification scheme for CDR‐H3 structure modeling. In addition, we determine the common features of CDR‐H3 in antibody drugs as well as discuss the concept of “antibody druggability,” which can be applied as an indicator of antibody evaluation during drug discovery. Proteins 2008. © 2008 Wiley‐Liss, Inc.

[1]  Haruki Nakamura,et al.  Structural classification of CDR‐H3 in antibodies , 1996, FEBS letters.

[2]  C. Lipinski.  Lead- and drug-like compounds: the rule-of-five revolution. , 2004, Drug discovery today. Technologies.

[3]  A. Rees,et al.  Antibody Variable Regions , 2004 .

[4]  A. Wu,et al.  The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility. , 2003, Journal of molecular biology.

[5]  A. Murzin,et al.  The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A R Rees,et al.  WAM: an improved algorithm for modelling antibodies on the WEB. , 2000, Protein engineering.

[7]  M Karplus,et al.  Molecular anatomy of the antibody binding site. , 1983, The Journal of biological chemistry.

[8]  A. Lesk,et al.  Standard conformations for the canonical structures of immunoglobulins. , 1997, Journal of molecular biology.

[9]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[10]  J. Engler,et al.  Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. , 2003, Journal of molecular biology.

[11]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[12]  Laurence Choulier,et al.  Effects on interaction kinetics of mutations at the VH–VL interface of Fabs depend on the structural context , 2000, Journal of molecular recognition : JMR.

[13]  R L Stanfield,et al.  Major antigen-induced domain rearrangements in an antibody. , 1993, Structure.

[14]  Robert J Woods,et al.  Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Shimba,et al.  Structural basis of the transition-state stabilization in antibody-catalyzed hydrolysis. , 2007, Journal of molecular biology.

[16]  J. Richardson,et al.  The anatomy and taxonomy of protein structure. , 1981, Advances in protein chemistry.

[17]  E. Padlan,et al.  Antibody-antigen complexes. , 1988, Annual review of biochemistry.

[18]  T. Okajima,et al.  Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation. , 2006, Molecular immunology.

[19]  Oleg V. Koliasnikov,et al.  Antibody Cdr H3 Modeling Rules: Extension for the Case of Absence of Arg H94 and Asp H101 , 2006, J. Bioinform. Comput. Biol..

[20]  M J Sternberg,et al.  Conformational analysis of the first observed non-proline cis-peptide bond occurring within the complementarity determining region (CDR) of an antibody. , 1998, Journal of molecular biology.

[21]  C. MacKenzie,et al.  Germline antibody recognition of distinct carbohydrate epitopes , 2003, Nature Structural Biology.

[22]  M. Lascombe,et al.  Three-dimensional structure of antibodies. , 1988, Annual review of immunology.

[23]  A. Kidera,et al.  Multicanonical Ensemble Generated by Molecular Dynamics Simulation for Enhanced Conformational Sampling of Peptides , 1997 .

[24]  M. Sternberg,et al.  Automated classification of antibody complementarity determining region 3 of the heavy chain (H3) loops into canonical forms and its application to protein structure prediction. , 1998, Journal of molecular biology.

[25]  N. Nakajima,et al.  Enhanced conformational diversity search of CDR‐H3 in antibodies: Role of the first CDR‐H3 residue , 1999, Proteins.

[26]  T. Keller,et al.  A practical view of 'druggability'. , 2006, Current opinion in chemical biology.

[27]  A Tramontano,et al.  Antibody structure, prediction and redesign. , 1997, Biophysical chemistry.

[28]  B. L. Sibanda,et al.  Beta-hairpin families in globular proteins. , 1985, Nature.

[29]  J. Martin Scholtz,et al.  Increasing protein conformational stability by optimizing β-turn sequence , 2007 .

[30]  A. Kidera,et al.  Conformational sampling of CDR-H3 in antibodies by multicanonical molecular dynamics simulation. , 1998, Journal of molecular biology.

[31]  A. Lesk,et al.  Conformations of immunoglobulin hypervariable regions , 1989, Nature.

[32]  Dan S. Tawfik,et al.  Antibody Multispecificity Mediated by Conformational Diversity , 2003, Science.

[33]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[34]  A. Lesk,et al.  Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.

[35]  C. Pace,et al.  Increasing protein conformational stability by optimizing beta-turn sequence. , 2007, Journal of molecular biology.

[36]  A Tramontano,et al.  Antibody modeling: implications for engineering and design. , 2000, Methods.

[37]  C. Chang,et al.  Dual conformations of an immunoglobulin light-chain dimer: heterogeneity of antigen specificity and idiotope profile may result from multiple variable-domain interaction mechanisms. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Rees,et al.  Antibody variable regions: toward a unified modeling method. , 2004, Methods in molecular biology.

[39]  Kuo-Chen Chou,et al.  Assessment of chemical libraries for their druggability , 2005, Comput. Biol. Chem..

[40]  C. Chothia,et al.  Domain association in immunoglobulin molecules. The packing of variable domains. , 1985, Journal of molecular biology.

[41]  A Tramontano,et al.  Conformations of the third hypervariable region in the VH domain of immunoglobulins. , 1998, Journal of molecular biology.

[42]  R. Schelonka,et al.  Categorical selection of the antibody repertoire in splenic B cells , 2007, European journal of immunology.

[43]  Haruki Nakamura,et al.  Announcing the worldwide Protein Data Bank , 2003, Nature Structural Biology.

[44]  Robyn L Stanfield,et al.  Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. , 2004, Structure.

[45]  Haruki Nakamura,et al.  H3‐rules: identification of CDR‐H3 structures in antibodies , 1999, FEBS letters.

[46]  B. L. Sibanda,et al.  β-Hairpin families in globular proteins , 1985, Nature.

[47]  B. L. Sibanda,et al.  Conformation of beta-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. , 1989, Journal of molecular biology.

[48]  Enrique Vargas‐Madrazo,et al.  An improved model of association for VH–VL immunoglobulin domains: Asymmetries between VH and VL in the packing of some interface residues , 2003, Journal of molecular recognition : JMR.

[49]  Andrew C. R. Martin,et al.  Accessing the Kabat antibody sequence database by computer , 1996, Proteins.

[50]  E. Padlan,et al.  Anatomy of the antibody molecule. , 1994, Molecular immunology.

[51]  Yuichi Sugiyama,et al.  Druggability: selecting optimized drug candidates. , 2005, Drug discovery today.

[52]  J. Novotný,et al.  Structural invariants of antigen binding: comparison of immunoglobulin VL-VH and VL-VL domain dimers. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Argos,et al.  Knowledge‐based protein secondary structure assignment , 1995, Proteins.